Taurine for longevity

At a Glance

Mechanism of Action

A conditionally essential sulphur-containing amino acid concentrated in heart, muscle and retina. Acts as an osmolyte, stabilises mitochondrial protein synthesis, conjugates bile acids and modulates calcium handling and GABA-A signalling.

Taurine is typically taken orally as powder (cheapest by far) or capsule, any time; split doses if taking above 3 g. A conditionally essential sulphur-containing amino acid concentrated in heart, muscle and retina. Acts as an osmolyte, stabilises mitochondrial protein synthesis, conjugates bile acids and modulates calcium handling and GABA-A signalling. Effective range is 500 mg - 6 g, with 1-3 g daily being the most-studied dose. It does not require food, and fasted dosing is often preferred for absorption or timing reasons.

Dosage & Timing

Splitting the daily dose keeps plasma concentrations steadier, which matters for compounds with a shorter half-life or narrower therapeutic window.

How to Take

1. Start at the lower end of the range (500 mg - 6 g) for the first 7–10 days to gauge tolerance.
2. Titrate up to the target dose of 1-3 g daily once tolerance is confirmed.
3. Fasted or with a light snack is acceptable — food is not required.
4. Best timing: Any time; split doses if taking above 3 g. Keep the daily window consistent so effects are legible against baseline.
5. Missed dose: skip and resume normally; never double up.

Absorption & Bioavailability

• Absorption for Taurine is generally reliable at 1-3 g daily; splitting the daily dose into two smaller servings can smooth plasma concentrations.
• Hydrate adequately — most oral supplements are absorbed better when total daily water intake is above 30 ml/kg.

Cycling & Stacking Strategy

• Most users run Taurine continuously and reassess every 12 weeks with bloods and a symptom log.
• If effect plateaus, a 2–4 week wash-out often restores responsiveness by resetting receptor sensitivity and feedback loops.
• Common stack: Magnesium glycinate, Creatine monohydrate, Omega-3. Introduce one addition at a time so you can attribute effect and side effect.
• Rotate related supplements seasonally rather than layering five products in the same category.

Who This Is For

What to Monitor

Reported Benefits

• Extended lifespan in mice and worms, and improved healthspan markers in monkeys
• Modest blood pressure reduction in hypertensive adults across small human trials
• Improved exercise performance markers in some athletic trials
• Very well tolerated — an unusually clean safety profile at gram doses

Safety Profile

How to Choose a Quality Product

• Third-party tested — look for NSF, Informed Sport, USP or an equivalent independent COA (certificate of analysis) on the batch you're buying.
• Standardised active — the label should specify the exact active compound and its concentration, not just the botanical name.
• Minimal excipients — avoid unnecessary fillers, artificial colours and shared allergens (soy, gluten) unless you're happy to test for reactions.
• Dose per serving matches the researched range (500 mg - 6 g) — many consumer products under-dose to widen margins.
• Manufactured in a cGMP-certified facility with a clear country of origin.
• Reasonable price per effective dose — cheaper products often deliver less active per capsule, so the true cost-per-dose is higher.

Common Mistakes

• Under-dosing — using 500 mg - 6 g when the research uses 1-3 g daily.
• Stopping after two weeks — most longevity-relevant endpoints need 8–12 weeks of consistent dosing before they move on bloods.
• No baseline labs, so any effect is attributed to placebo or hype rather than to the supplement.
• Stacking three or four new products in the same month — you lose all ability to attribute results.
• Buying the cheapest brand and skipping the third-party COA — potency and purity vary dramatically between manufacturers.
• Timing it inconsistently — the biological effect depends on steady exposure, not sporadic doses.

Evidence Grade — C (42/100)

Grade C — mechanistic hypothesis, in-vitro or animal data only. Human evidence is preliminary or anecdotal. Treat as experimental.

The primary references used to grade Taurine are listed below. Cross-check against the current literature and expect the grade to move as new human trials publish.

References

1. [1]Taurine deficiency as a driver of aging — Science, 2023
2. [2]Experimental evidence against taurine deficiency as a driver of aging in humans — Aging Cell, 2025

Further reading: Research library → · Protocols →